Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
18000 West 99th Street , Lenexa, KS, 66219, US
With over 40 years of experience, we provide a seamless, solutions-based approach for safety, bioanalytical, and specialty testing, as well as clinical trial IMP supplies, in support of phase I to IV clinical trials. Our integrated solutions deliver the most comprehensive range of state-of-the-art analytical technologies around the world.
BAT2506 is a proposed golimumab biosimilar developed by Bio-Thera.
By: Charlie Sternberg
Thermo Fisher to acquire Sanofi’s steriles manufacturing site in Ridgefield, NJ and continue to manufacture a portfolio of therapies for Sanofi.
RZL-012 is an injectable treatment for focal fat reduction that is currently progressing toward Phase 3 trials.
Kane will advance strategic priorities and advance Solrikitug, its lead asset, in Phase II trials and prepare for Phase III.
By: Rachel Klemovitch
Will support PCI's growth initiatives, including expanding its suite of services and geographic reach.
Aim to deliver an advanced, fully tested, fully automated robotically operated CGT manufacturing platform to the market.
Through this acquisition Merck will add Ohtuvayre to its growing cardio-pulmonary pipeline and portfolio.
New appointments to the leadership team also include Stefan Larson as Chair of the Board of Directors and Ingmar Bruns as a new Board Member.
SC 4/2V and SC 4/3V offer dramatically improved safety and reliability for transporting and preserving sensitive biological materials at cryogenic temperatures.
Dr. Richard Philipson has 25+ years of industry experience and a successful track record in drug development.
Completes multi-million dollar investment at its global headquarters in Craigavon, Northern Ireland.
Enables Circio to further accelerate pre-clinical development towards its first therapeutic candidates.
Welcomes Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff.
Forms a rare tumor business for Merck KGaA, Darmstadt, Germany, including SpringWorks’ portfolio and pimicotinib.
The U.S. launch of Conexxence and Bomyntra follows the FDA’s approval in March 2025.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
